CLINICAL_TRIALS
trial_result
· 2015-01-28
Clinical Trial Update: Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients [Phase 3]
Summary
A Phase 3 trial evaluating macitentan for digital ulcers in systemic sclerosis was terminated, and results were posted in January 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Actelion | Conditions: Digital Ulcers | Phase 3 | Status: TERMINATED | Results posted: 2015-01-28